Well Lead Med Co Ltd (603309) — Working Capital to Net Assets Ratio
Well Lead Med Co Ltd (603309) has a Working Capital to Net Assets ratio of 20.3% as of June 2026. Working capital of CN¥362.90 Million (current assets of CN¥856.43 Million minus current liabilities of CN¥493.53 Million) is measured against net assets of CN¥1.79 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Well Lead Med Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Well Lead Med Co Ltd Working Capital to Net Assets (2011–2025)
This chart shows how Well Lead Med Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 20.3%, reflecting working capital of CN¥362.90 Million against net assets of CN¥1.79 Billion CNY. For the complete balance sheet picture, see total assets of Well Lead Med Co Ltd.
Annual Working Capital to Net Assets for Well Lead Med Co Ltd (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Well Lead Med Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 603309 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 18.5% | CN¥329.54 Million | CN¥1.78 Billion | CN¥967.19 Million | CN¥637.65 Million | ▼ -0.1 pp |
| 2024 | 18.6% | CN¥354.28 Million | CN¥1.90 Billion | CN¥886.06 Million | CN¥531.79 Million | ▼ -1.9 pp |
| 2023 | 20.5% | CN¥376.19 Million | CN¥1.84 Billion | CN¥817.39 Million | CN¥441.20 Million | ▼ -9.2 pp |
| 2022 | 29.7% | CN¥516.73 Million | CN¥1.74 Billion | CN¥994.11 Million | CN¥477.38 Million | ▼ -4.7 pp |
| 2021 | 34.4% | CN¥547.99 Million | CN¥1.59 Billion | CN¥974.54 Million | CN¥426.55 Million | ▲ +17.3 pp |
| 2020 | 17.2% | CN¥196.26 Million | CN¥1.14 Billion | CN¥434.94 Million | CN¥238.68 Million | ▼ -1.1 pp |
| 2019 | 18.3% | CN¥189.35 Million | CN¥1.04 Billion | CN¥420.42 Million | CN¥231.08 Million | ▲ +4.1 pp |
| 2018 | 14.1% | CN¥132.94 Million | CN¥940.07 Million | CN¥391.43 Million | CN¥258.49 Million | ▼ -38.5 pp |
| 2017 | 52.6% | CN¥473.58 Million | CN¥900.07 Million | CN¥577.19 Million | CN¥103.61 Million | ▼ -5.9 pp |
| 2016 | 58.5% | CN¥505.28 Million | CN¥863.31 Million | CN¥607.00 Million | CN¥101.72 Million | ▼ -4.3 pp |
| 2015 | 62.9% | CN¥489.45 Million | CN¥778.65 Million | CN¥583.73 Million | CN¥94.28 Million | ▲ +36.4 pp |
| 2014 | 26.4% | CN¥97.82 Million | CN¥370.18 Million | CN¥244.68 Million | CN¥146.87 Million | ▲ +5.4 pp |
| 2013 | 21.0% | CN¥63.47 Million | CN¥302.37 Million | CN¥225.67 Million | CN¥162.21 Million | ▼ -3.6 pp |
| 2012 | 24.6% | CN¥61.25 Million | CN¥249.37 Million | CN¥194.11 Million | CN¥132.86 Million | ▼ -11.3 pp |
| 2011 | 35.9% | CN¥69.40 Million | CN¥193.41 Million | CN¥193.64 Million | CN¥124.24 Million | — |